{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T12:33:21Z","timestamp":1773318801155,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Primary Care: Clinics in Office Practice"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.pop.2013.06.002","type":"journal-article","created":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T06:45:44Z","timestamp":1373957144000},"page":"637-654","source":"Crossref","is-referenced-by-count":39,"title":["Methicillin-Resistant Staphylococcus Aureus Infections"],"prefix":"10.1016","volume":"40","author":[{"given":"Abraham R.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pop.2013.06.002_bib1","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.298.15.1763","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections in the United States","volume":"298","author":"Klevens","year":"2007","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.pop.2013.06.002_bib2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ajic.2007.10.009","article-title":"National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US healthcare facilities, 2006","volume":"35","author":"Jarvis","year":"2007","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.pop.2013.06.002_bib3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajic.2012.02.001","article-title":"National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at United States health care facilities, 2010","volume":"40","author":"Jarvis","year":"2012","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.pop.2013.06.002_bib4","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1001\/archinte.165.15.1756","article-title":"The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 nationwide inpatient sample database","volume":"165","author":"Noskin","year":"2005","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.pop.2013.06.002_bib5","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3201\/eid1211.060190","article-title":"Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care","volume":"12","author":"McCraig","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.pop.2013.06.002_bib6","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJMoa055356","article-title":"Methicillin-resistant S. aureus infections among patients in the emergency department","volume":"355","author":"Moran","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pop.2013.06.002_bib7","unstructured":"Gorwitz RJ, Jernigan DB, Powers JH, et\u00a0al. Participants in the CDC-Convened Experts\u2019 Meeting on Management of MRSA in the Community. Strategies for clinical management of MRSA in the community: summary of an experts\u2019 meeting convened by the Center for Disease Control and Prevention. 2006. Available at: http:\/\/www.cdc.gov\/ncidod\/dhqp\/ar_mrsa_ca.html. Accessed February 17, 2013."},{"key":"10.1016\/j.pop.2013.06.002_bib8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jhin.2005.07.011","article-title":"Case definition for community-associated methicillin-resistant Staphylococcus aureus","volume":"62","author":"Morrison","year":"2006","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.pop.2013.06.002_bib9","series-title":"Methicillin-resistant Staphylococcus aureus (MRSA) infections: diagnosis and testing","author":"CDC","year":"2010"},{"key":"10.1016\/j.pop.2013.06.002_bib10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/427148","article-title":"Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes","volume":"40","author":"Francis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pop.2013.06.002_bib11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.idc.2005.05.011","article-title":"Implications of methicillin-resistant Staphylococcus aureus as a community-acquired pathogen in pediatric patients","volume":"19","author":"Kaplan","year":"2005","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.pop.2013.06.002_bib12","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1056\/NEJMoa044194","article-title":"Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children","volume":"353","author":"Adem","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pop.2013.06.002_bib13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1086\/499632","article-title":"Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002","volume":"193","author":"Kuehnert","year":"2006","journal-title":"J\u00a0Infect Dis"},{"issue":"7","key":"10.1016\/j.pop.2013.06.002_bib14","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/01.inf.0000168746.62226.a4","article-title":"Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children","volume":"24","author":"Creech","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.pop.2013.06.002_bib15","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/j.ajic.2007.10.006","article-title":"Management of multidrug-resistant organisms in healthcare settings, 2006","volume":"35","author":"Seigel","year":"2007","journal-title":"Am J Infect Control"},{"issue":"1","key":"10.1016\/j.pop.2013.06.002_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/657665","article-title":"Sustained reduction in the clinical incidence of methicillin-resistant Staphylococcus aureus colonization or infection associated with a multifaceted infection control intervention","volume":"32","author":"Ellingson","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.pop.2013.06.002_bib17","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1086\/507636","article-title":"Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia","volume":"43","author":"Huang","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.pop.2013.06.002_bib18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-148-6-200803180-00003","article-title":"Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals","volume":"148","author":"Robicsek","year":"2008","journal-title":"Ann Intern Med"},{"issue":"39","key":"10.1016\/j.pop.2013.06.002_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7390","article-title":"Systematic review of isolation policies in\u00a0the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modeling","volume":"7","author":"Cooper","year":"2003","journal-title":"Health Technol Assess"},{"issue":"7465","key":"10.1016\/j.pop.2013.06.002_bib20","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/bmj.329.7465.533","article-title":"Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature","volume":"329","author":"Cooper","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.pop.2013.06.002_bib21","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1086\/587901","article-title":"The use of active surveillance cultures in adult ICUs to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality and costs: a systematic review","volume":"46","author":"McGinigle","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.pop.2013.06.002_bib22","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/jama.2010.1115","article-title":"Health care\u2013associated invasive MRSA infections, 2005-2008","volume":"304","author":"Kallen","year":"2010","journal-title":"J\u00a0Am Med Assoc"},{"issue":"7","key":"10.1016\/j.pop.2013.06.002_bib23","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jama.2009.153","article-title":"Methicillin-resistant Staphylococcus aureus central line\u2013associated bloodstream infections in US intensive care units, 1997-2007","volume":"301","author":"Burton","year":"2009","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.pop.2013.06.002_bib24","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1086\/656623","article-title":"An antimicrobial stewardship program\u2019s impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus\/S. aureus blood culture test in patients with S. aureus bacteremia","volume":"51","author":"Bauer","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.pop.2013.06.002_bib25","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2165\/11533020-000000000-00000","article-title":"Impact of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing on mortality and cost effectiveness in hospitalized patients with bacteraemia: a decision model","volume":"28","author":"Brown","year":"2010","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.pop.2013.06.002_bib26","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1128\/JCM.00326-08","article-title":"Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant Enterococcus species","volume":"46","author":"Malhotra-Kumar","year":"2008","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.pop.2013.06.002_bib27","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1128\/JCM.00399-06","article-title":"Use of BBL CHROMagar MRSA medium for identification of methicillin-resistant Staphylococcus aureus directly from blood cultures","volume":"44","author":"Pape","year":"2006","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.pop.2013.06.002_bib28","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1128\/JCM.01714-08","article-title":"Multicenter evaluation of the cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares","volume":"47","author":"Wolk","year":"2009","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.pop.2013.06.002_bib29","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1128\/JCM.01884-08","article-title":"Rapid detection of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) in wound specimens and blood cultures: multicenter preclinical evaluation of the Cepheid Xpert MRSA\/SA skin and soft tissue and blood culture assays","volume":"47","author":"Wolk","year":"2009","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.pop.2013.06.002_bib30","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2146\/ajhp110724","article-title":"Rapid testing for methicillin-resistant Staphylococcus aureus: implications for antimicrobial stewardship","volume":"70","author":"Geiger","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.pop.2013.06.002_bib31","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1128\/JCM.02967-12","article-title":"Controlled multicenter evaluation of a bacteriophage based method for the rapid detection of Staphylococcus aureus in positive blood cultures","volume":"51","author":"Bhowmick","year":"2013","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.pop.2013.06.002_bib32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.diagmicrobio.2011.11.012","article-title":"Evaluation of the BinaxNOW PBP2a assay for the direct detection of methicillin resistant Staphylococcus aureus from positive blood cultures","volume":"72","author":"Romero-G\u00f3mez","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.pop.2013.06.002_bib33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.diagmicrobio.2006.10.021","article-title":"Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents","volume":"58","author":"Tsuji","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.pop.2013.06.002_bib34","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Disease Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"47","key":"10.1016\/j.pop.2013.06.002_bib35","first-page":"1201","article-title":"Severe clostridium difficile-associated disease in populations previously at low risk-four states, 2005","volume":"54","author":"Center for Disease Control and Prevention","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.pop.2013.06.002_bib36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijantimicag.2006.04.013","article-title":"Risk factors for clostridium difficile toxin-positive nosocomial diarrhoea","volume":"28","author":"Raveh","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.pop.2013.06.002_bib37","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1001\/jama.290.22.2976","article-title":"Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection","volume":"290","author":"Naimi","year":"2003","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.pop.2013.06.002_bib38","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa043252","article-title":"Methicillin-resistant Staphylococcus aureus disease in three communities","volume":"352","author":"Fridkin","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pop.2013.06.002_bib39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1086\/646499","article-title":"Antimicrobial therapy for methicillin-resistant Staphylococcus aureus colonization in residents and staff of a Veterans Affairs nursing home care unit","volume":"13","author":"Strausbaugh","year":"1992","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.pop.2013.06.002_bib40","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00042-09","article-title":"Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogenous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications","volume":"23","author":"Howden","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.pop.2013.06.002_bib41","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJMoa025025","article-title":"Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene","volume":"348","author":"Chang","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pop.2013.06.002_bib42","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ijantimicag.2007.07.011","article-title":"Reduced glycopeptides susceptibility in methicillin-resistant Staphylococcus aureus (MRSA)","volume":"30","author":"Appelbaum","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.pop.2013.06.002_bib43","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1128\/AAC.47.10.3040-3045.2003","article-title":"Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods","volume":"47","author":"Liu","year":"2003","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.pop.2013.06.002_bib44","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1086\/421092","article-title":"Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy","volume":"38","author":"Moise-Broder","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pop.2013.06.002_bib45","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1086\/429628","article-title":"Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infectiosn: case series and review of the literature","volume":"40","author":"Ruhe","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pop.2013.06.002_bib46","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1128\/AAC.34.8.1611","article-title":"Gene heterogeneity for tetracycline resistance in multidrug-resistant, community-associated methicillin-resistant Staphylococcus spp","volume":"34","author":"Bismuth","year":"1990","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.pop.2013.06.002_bib47","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1086\/598510","article-title":"Doxycycline, not minocycline, induces its own resistance in multidrug-resistant, community-associated methicillin-resistant Staphylococcus aureus clone USA300","volume":"48","author":"Schwartz","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pop.2013.06.002_bib48","first-page":"103","article-title":"A\u00a0comparative trial of minocycline and cloxacillin in the treatment of soft tissue infections due to tetracycline resistant Staphylococcus aureus","volume":"3","author":"Alausa","year":"1976","journal-title":"West Afr J Pharmacol Drug Res"},{"key":"10.1016\/j.pop.2013.06.002_bib49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(01)05410-1","article-title":"Linezolid resistance in a clinical isolate of Staphylococcus aureus","volume":"358","author":"Tsiodras","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.pop.2013.06.002_bib50","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1086\/340710","article-title":"Serotonin syndrome and linezolid","volume":"34","author":"Wigen","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pop.2013.06.002_bib51","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1080\/00365540500263110","article-title":"Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid","volume":"37","author":"Corne","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.pop.2013.06.002_bib52","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1086\/342698","article-title":"Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid","volume":"35","author":"Ruiz","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pop.2013.06.002_bib53","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1086\/520655","article-title":"Perspectives on daptomycin resistance, with emphasis on resistance in Staphylococcus aureus","volume":"54","author":"Boucher","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pop.2013.06.002_bib54","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1128\/JCM.44.2.595-597.2006","article-title":"Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis","volume":"44","author":"Marty","year":"2006","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.pop.2013.06.002_bib55","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1128\/AAC.50.4.1581-1585.2006","article-title":"Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin","volume":"50","author":"Sakoulas","year":"2006","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.pop.2013.06.002_bib56","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1086\/504084","article-title":"An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus","volume":"42","author":"Patel","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pop.2013.06.002_bib57","first-page":"282","article-title":"New antimicrobial agents for methicillin-resistant Staphylococcus aureus","volume":"11","author":"Kollef","year":"2009","journal-title":"Crit Care Resusc"},{"key":"10.1016\/j.pop.2013.06.002_bib58","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2217\/17460913.4.1.25","article-title":"Ceftaroline: a cephalosporin with expanded gram-positive activity","volume":"4","author":"Kanafani","year":"2009","journal-title":"Future Microbiol"},{"key":"10.1016\/j.pop.2013.06.002_bib59","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1128\/AAC.00377-07","article-title":"Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection","volume":"51","author":"Rajendran","year":"2007","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.pop.2013.06.002_bib60","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.annemergmed.2009.03.014","article-title":"Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient","volume":"55","author":"Duong","year":"2010","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.pop.2013.06.002_bib61","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.annemergmed.2010.03.002","article-title":"Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection","volume":"56","author":"Schmitz","year":"2010","journal-title":"Ann Emerg Med"},{"issue":"4","key":"10.1016\/j.pop.2013.06.002_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006216.pub2","article-title":"Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers","author":"Van Rijen","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.pop.2013.06.002_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003340","article-title":"Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization","author":"Loeb","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.pop.2013.06.002_bib64","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1086\/377735","article-title":"Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidenced-based review","volume":"37","author":"Laupland","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.pop.2013.06.002_bib65","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1001\/archinte.1996.00040041109010","article-title":"A\u00a01-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection","volume":"156","author":"Raz","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pop.2013.06.002_bib66","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/431979","article-title":"Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database","volume":"41","author":"Miro","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pop.2013.06.002_bib67","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1001\/jama.293.24.3012","article-title":"Staphylococcus aureus endocarditis: a consequence of medical progress","volume":"293","author":"Fowler","year":"2005","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.pop.2013.06.002_bib68","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1001\/archinte.163.17.2066","article-title":"Clinical identifiers of complicated Staphylococcus aureus bacteremia","volume":"163","author":"Fowler","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pop.2013.06.002_bib69","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1086\/320001","article-title":"Guidelines for the management of intravascular catheter\u2013related infections","volume":"32","author":"Mermel","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pop.2013.06.002_bib70","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/0003-4819-115-9-674","article-title":"Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis","volume":"115","author":"Levine","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pop.2013.06.002_bib71","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1128\/AAC.00300-08","article-title":"Addition of rifampin to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus","volume":"52","author":"Riedel","year":"2008","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.pop.2013.06.002_bib72","doi-asserted-by":"crossref","first-page":"496","DOI":"10.7326\/0003-4819-97-4-496","article-title":"Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study","volume":"97","author":"Korzeniowski","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pop.2013.06.002_bib73","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1161\/CIRCULATIONAHA.105.165564","volume":"111","author":"Baddour","year":"2005","journal-title":"Circulation"},{"issue":"S5","key":"10.1016\/j.pop.2013.06.002_bib74","doi-asserted-by":"crossref","first-page":"S386","DOI":"10.1086\/533595","article-title":"Management of methicillin-resistant Staphylococcus aureus bacteremia","volume":"46","author":"Cosgrove","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pop.2013.06.002_bib75","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/CCM.0b013e3181b9ecea","article-title":"Effect of vancomycin plus rifampin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia","volume":"38","author":"Jung","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.pop.2013.06.002_bib76","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0149-2918(03)80118-2","article-title":"Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia","volume":"25","author":"Wunderink","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.pop.2013.06.002_bib77","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1086\/318486","article-title":"Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study","volume":"32","author":"Rubinstein","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pop.2013.06.002_bib78","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1378\/chest.124.5.1789","article-title":"Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia","volume":"124","author":"Wunderink","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.pop.2013.06.002_bib79","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/jama.279.19.1537","article-title":"Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group","volume":"279","author":"Zimmerli","year":"1998","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.pop.2013.06.002_bib80","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/jac\/dkl017","article-title":"Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK","volume":"57","author":"Gemmel","year":"2006","journal-title":"J\u00a0Antimicrob Chemother"}],"container-title":["Primary Care: Clinics in Office Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009545431300064X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009545431300064X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T10:03:03Z","timestamp":1563444183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009545431300064X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S009545431300064X"],"URL":"https:\/\/doi.org\/10.1016\/j.pop.2013.06.002","relation":{},"ISSN":["0095-4543"],"issn-type":[{"value":"0095-4543","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}